Articles published by Pfizer Inc.
Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata
September 09, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 06, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action
September 06, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences
September 01, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
August 19, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants
August 12, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
From Pfizer Inc.
Via Business Wire
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
August 08, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
PFIZER REPORTS SECOND-QUARTER 2022 RESULTS
July 28, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts
June 24, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Declares Third-Quarter 2022 Dividend
June 23, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA
June 14, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Pfizer Completes Acquisition of ReViral
June 09, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free